Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
83,493
Value
$7.58M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202683,493$7.58M0.2%−2,516−2.9%ReducedHolders
Q1 202686,009$8.83M0.2%−7,313−7.8%ReducedHolders
Q4 202593,322$11.7M0.3%−6,536−6.5%ReducedHolders
Q3 202599,858$13.4M0.3%+50+0.1%AddedHolders
Q2 202599,808$13.6M0.3%+11,734+13.3%AddedHolders
Q1 202588,074$11.7M0.3%+11,629+15.2%AddedHolders
Q4 202476,445$8.65M0.2%−280.0%ReducedHolders
Q3 202476,473$8.72M0.2%−319−0.4%ReducedHolders
Q2 202476,792$7.98M0.2%−427−0.6%ReducedHolders
Q1 202477,219$8.78M0.2%−320.0%ReducedHolders
Q4 202377,251$8.50M0.3%−334−0.4%ReducedHolders
Q3 202377,585$7.51M0.2%+7,296+10.4%AddedHolders
Q2 202370,289$7.66M0.3%−6,991−9.0%ReducedHolders
Q1 202377,280$7.83M0.3%−464−0.6%ReducedHolders
Q4 202277,744$8.54M0.3%−1,102−1.4%ReducedHolders
Q3 202278,846$7.63M0.3%+344+0.4%AddedHolders
Q2 202278,502$8.53M0.3%−1,377−1.7%ReducedHolders
Q1 202279,879$9.46M0.3%−449−0.6%ReducedHolders
Q4 202180,328$11.3M0.4%+213+0.3%AddedHolders
Q3 202180,115$9.46M0.3%+150+0.2%AddedHolders
Q2 202179,965$9.27M0.3%−3,576−4.3%ReducedHolders
Q1 202183,541$10.0M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.